Medicus Pharma (MDCX) Total Debt (2025 - 2026)

Medicus Pharma's (MDCX) quarterly Total Debt came in at $5.3 million in Q4 2025, down 22.65% on a QoQ basis from $6.8 million in Q3 2025.

Medicus Pharma (MDCX) Total Debt (2025 - 2026) Analysis & Trends

Medicus Pharma (MDCX) has 1 years of Total Debt data on file, last reported at $5.3 million in Q4 2025.

Quarterly Total Debt changed N/A year-over-year to $5.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $5.3 million (changed N/A YoY) and the FY2025 annual result came in at $5.3 million, changed N/A from the prior year.
Total Debt retreated to $5.3 million in Q4 2025, from $6.8 million in the prior quarter.
In the past five years, Total Debt ranged from a high of $6.8 million in Q3 2025 to a low of $4.7 million in Q2 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Total Debt (Qtr)
1	Johnson & Johnson	652.20 Bn	631.44 Bn	17.26 Bn	49.04 Bn
2	AbbVie	469.51 Bn	462.94 Bn	12.70 Bn	70.82 Bn
3	Merck	376.81 Bn	369.67 Bn	12.21 Bn	53.91 Bn
4	Novartis Ag	303.04 Bn	295.35 Bn	11.24 Bn	9.59 Bn
5	Astrazeneca	257.61 Bn	252.71 Bn	12.86 Bn	29.49 Bn
6	Amgen	237.37 Bn	223.38 Bn	7.24 Bn	62.75 Bn
7	Gilead Sciences	181.73 Bn	178.55 Bn	6.22 Bn	28.66 Bn
8	Pfizer	159.66 Bn	147.96 Bn	10.94 Bn	63.19 Bn
9	Gsk	106.24 Bn	102.07 Bn	8.24 Bn	-25.96 Bn
10	Medicus Pharma	14.88 Mn	-298,205.43	-	21.48 Mn

Download Data